108139
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.4 Breast Cancer (Dove Med Press)
- 3.2 Clin Epidemiol
- 2.6 Cancer Manag Res
- 2.9 Infect Drug Resist
- 3.7 Clin Interv Aging
- 5.1 Drug Des Dev Ther
- 3.1 Int J Chronic Obstr
- 6.6 Int J Nanomed
- 2.6 Int J Women's Health
- 2.9 Neuropsych Dis Treat
- 2.8 OncoTargets Ther
- 2.0 Patient Prefer Adher
- 2.2 Ther Clin Risk Manag
- 2.5 J Pain Res
- 3.0 Diabet Metab Synd Ob
- 3.2 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 1.8 Pharmgenomics Pers Med
- 2.0 Risk Manag Healthc Policy
- 4.1 J Inflamm Res
- 2.0 Int J Gen Med
- 3.4 J Hepatocell Carcinoma
- 3.0 J Asthma Allergy
- 2.2 Clin Cosmet Investig Dermatol
- 2.4 J Multidiscip Healthc
已发表论文
维生素 K 缺乏或拮抗剂诱导的凝血酶原诱导蛋白（PIVKA）与α-L-岩藻糖苷酶（AFU）联合甲胎蛋白（AFP）检测可能提高慢性乙型肝炎肝硬化及肝细胞癌的诊断效能
Authors Hou H, Weng R, Liang L, Han W
Received 15 June 2025
Accepted for publication 26 September 2025
Published 2 October 2025 Volume 2025:18 Pages 6031—6042
DOI https://doi.org/10.2147/IJGM.S547252
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Professor Hyam Leffert
Haisong Hou,1 Ruiqiang Weng,2 Liu Liang,3 Wendao Han1
1Department of Blood Transfusion, Meizhou People’s Hospital, Meizhou Academy of Medical Sciences, Meizhou, People’s Republic of China; 2Institute of Basic Medical Sciences, Meizhou People’s Hospital, Meizhou Academy of Medical Sciences, Meizhou, People’s Republic of China; 3Department of Laboratory Medicine, Meizhou People’s Hospital, Meizhou Academy of Medical Sciences, Meizhou, People’s Republic of China
Correspondence: Haisong Hou, Department of Blood Transfusion, Meizhou People’s Hospital, Meizhou Academy of Medical Sciences, Meizhou, People’s Republic of China, Email houhaisonggd6@163.com
Background: The aim of this study was to explore the value of biomarkers such as prothrombin induced by vitamin K absence (PIVKA), osteopontin (OPN), α-L-fucoidase (AFU), interleukin-6 (IL-6), and Golgi protein 73 (GP73) in the diagnosis of chronic hepatitis B (CHB), hepatitis B liver cirrhosis (HBV-LC), and hepatocellular carcinoma (HCC).
Methods: A total of 264 male patients were included in this study, including CHB (n=88), HBV-LC (n=88), and HCC (n=88). The levels of PIVKA, OPN, AFU, alpha-fetoprotein (AFP), IL6, and GP73 of the subjects were detected respectively, and the differences in the levels of serum PIVKA, OPN, AFU, AFP, IL6 and GP73 among the groups were compared. The correlations among various indicators were analyzed, and the diagnostic value of these indicators for HBV-LC and HCC was evaluated through the receiver operating characteristic (ROC) curve analysis.
Results: The levels of PIVKA, OPN, AFP, AFU, IL6, and GP73 in patients with HBV-LC, HCC were significantly higher than those in patients with CHB, respectively. In patients with HBV-LC and HCC, no significant correlation was shown between AFP and other markers, suggesting that AFP may have an independent mechanism of action different from other markers in HBV-LC and HCC. OPN had the highest diagnostic efficacy, with an area under the ROC curve (AUC) of 0.855 in diagnosis of HBV-LC, followed by GP73 and IL6. AFU had the highest diagnostic efficacy in diagnosis of HCC, followed by AFP and OPN. In terms of combined detection, the diagnostic efficacy of AFP+AFU (AUC=0.785, 95% CI: 0.714– 0.855) and AFP+PIVKA (AUC=0.635, 95% CI: 0.553– 0.718) were better than AFP in diagnosing HBV-LC; and the diagnostic efficacy of AFP+AFU (AUC=0.878, 95% CI: 0.822– 0.934) was better than AFP in diagnosing HCC.
Conclusion: Combined analysis of PIVKA and AFU with AFP may improve the diagnostic efficacy for HBV-LC and HCC in CHB.
Keywords: chronic hepatitis B, liver cirrhosis, hepatocellular carcinoma, prothrombin induced by vitamin K absence, alpha-L-fucosidase
1Department of Blood Transfusion, Meizhou People’s Hospital, Meizhou Academy of Medical Sciences, Meizhou, People’s Republic of China; 2Institute of Basic Medical Sciences, Meizhou People’s Hospital, Meizhou Academy of Medical Sciences, Meizhou, People’s Republic of China; 3Department of Laboratory Medicine, Meizhou People’s Hospital, Meizhou Academy of Medical Sciences, Meizhou, People’s Republic of China
Correspondence: Haisong Hou, Department of Blood Transfusion, Meizhou People’s Hospital, Meizhou Academy of Medical Sciences, Meizhou, People’s Republic of China, Email houhaisonggd6@163.com
Background: The aim of this study was to explore the value of biomarkers such as prothrombin induced by vitamin K absence (PIVKA), osteopontin (OPN), α-L-fucoidase (AFU), interleukin-6 (IL-6), and Golgi protein 73 (GP73) in the diagnosis of chronic hepatitis B (CHB), hepatitis B liver cirrhosis (HBV-LC), and hepatocellular carcinoma (HCC).
Methods: A total of 264 male patients were included in this study, including CHB (n=88), HBV-LC (n=88), and HCC (n=88). The levels of PIVKA, OPN, AFU, alpha-fetoprotein (AFP), IL6, and GP73 of the subjects were detected respectively, and the differences in the levels of serum PIVKA, OPN, AFU, AFP, IL6 and GP73 among the groups were compared. The correlations among various indicators were analyzed, and the diagnostic value of these indicators for HBV-LC and HCC was evaluated through the receiver operating characteristic (ROC) curve analysis.
Results: The levels of PIVKA, OPN, AFP, AFU, IL6, and GP73 in patients with HBV-LC, HCC were significantly higher than those in patients with CHB, respectively. In patients with HBV-LC and HCC, no significant correlation was shown between AFP and other markers, suggesting that AFP may have an independent mechanism of action different from other markers in HBV-LC and HCC. OPN had the highest diagnostic efficacy, with an area under the ROC curve (AUC) of 0.855 in diagnosis of HBV-LC, followed by GP73 and IL6. AFU had the highest diagnostic efficacy in diagnosis of HCC, followed by AFP and OPN. In terms of combined detection, the diagnostic efficacy of AFP+AFU (AUC=0.785, 95% CI: 0.714– 0.855) and AFP+PIVKA (AUC=0.635, 95% CI: 0.553– 0.718) were better than AFP in diagnosing HBV-LC; and the diagnostic efficacy of AFP+AFU (AUC=0.878, 95% CI: 0.822– 0.934) was better than AFP in diagnosing HCC.
Conclusion: Combined analysis of PIVKA and AFU with AFP may improve the diagnostic efficacy for HBV-LC and HCC in CHB.
Keywords: chronic hepatitis B, liver cirrhosis, hepatocellular carcinoma, prothrombin induced by vitamin K absence, alpha-L-fucosidase